Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

To understand functional consequences of genetic and transcriptional aberrations in prostate cancer, the proteomic changes during disease formation and progression need to be revealed. Here we report high-throughput mass spectrometry on clinical tissue samples of benign prostatic hyperplasia (BPH),...

Descripción completa

Detalles Bibliográficos
Autores principales: Latonen, Leena, Afyounian, Ebrahim, Jylhä, Antti, Nättinen, Janika, Aapola, Ulla, Annala, Matti, Kivinummi, Kati K., Tammela, Teuvo T. L., Beuerman, Roger W., Uusitalo, Hannu, Nykter, Matti, Visakorpi, Tapio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862881/
https://www.ncbi.nlm.nih.gov/pubmed/29563510
http://dx.doi.org/10.1038/s41467-018-03573-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862881/
https://www.ncbi.nlm.nih.gov/pubmed/29563510
http://dx.doi.org/10.1038/s41467-018-03573-6

Ejemplares similares